Abstract

Vaccinia virus (VACV) was used as a surrogate of variola virus (VARV) (genus Orthopoxvirus), the causative agent of smallpox, to study Orthopoxvirus infection. VARV is principally transmitted between humans by aerosol droplets. Once inhaled, VARV first infects the respiratory tract where it could encounter surfactant components, such as soluble pattern recognition receptors. Surfactant protein D (SP-D), constitutively present in the lining fluids of the respiratory tract, plays important roles in innate host defense against virus infection. We investigated the role of SP-D in VACV infection and studied the A27 viral protein involvement in the interaction with SP-D. Interaction between SP-D and VACV caused viral inhibition in a lung cell model. Interaction of SP-D with VACV was mediated by the A27 viral protein. Binding required Ca2+ and interactions were blocked in the presence of excess of SP-D saccharide ligands. A27, which lacks glycosylation, directly interacted with SP-D. The interaction between SP-D and the viral particle was also observed using electron microscopy. Infection of mice lacking SP-D (SP-D-/-) resulted in increased mortality compared to SP-D+/+ mice. Altogether, our data show that SP-D participates in host defense against the vaccinia virus infection and that the interaction occurs with the viral surface protein A27.

Highlights

  • Vaccinia virus (VACV) is the prototype for the Poxviridae family and the Orthopoxvirus genus which includes variola virus (VARV), the etiological agent of smallpox

  • Proteins bound to the membranes were detected using a specific anti-surfactant protein antibody and enhanced chemiluminescence

  • Nonspecific signal was comparable to the signals observed with human alveolar proteinosis surfactant protein A (AP-surfactant proteins (SP)-A) and human recombinant surfactant protein A (RhSP-A)

Read more

Summary

Introduction

Vaccinia virus (VACV) is the prototype for the Poxviridae family and the Orthopoxvirus genus which includes variola virus (VARV), the etiological agent of smallpox. IAV expressing the HA of pandemic viruses were associated with significant pathology of the lower respiratory tract and showed a low binding activity for SP-D while virus expressing HA of a seasonal strain induced only mild disease and exhibited strong in vitro binding to SP-D [29, 34]. These studies established that the innate immune activity of SP-D is principally mediated through interaction with viral membrane glycoproteins. Scheme adapted from [50]

Vaccinia virus interaction with surfactant protein D
SP-D inhibits VACV infectivity
Multimeric SP-D but not NCRD domains inhibits VACV infectivity
Recombinant A27 viral protein binds to SP-D
SP-D binding to viral particle
Characterization of the interaction between SP-D and recombinant A27
Protective role of SP-D in VACV infection in mice model
Cells and viruses
Reagents
Recombinant surfactant proteins
Other recombinant proteins
A27 viral protein expression and purification
A27 SDS-PAGE and western-blot analyses
Surfactant protein interaction with VACV strains by overlay assay
Lectins-virus infection inhibition assay
3.10. Binding of SP-D to A27 recombinant VACV protein
3.12. Electron Microscopy
3.13. Surface plasmon resonance analyses on immobilized SP-D
3.14. Surface plasmon resonance analyses on immobilized A27 viral protein
3.15. Surface Plasmon resonance data evaluation
3.16. Ethics Statement
3.17. Animals
3.18. VACV-WR intranasal infection model
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.